We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Sugar Molecules, Not Antibodies, Used to Detect Influenza Viruses

By Labmedica staff writers
Posted on 14 Jul 2008
A fast, sensitive test uses sugar molecules rather than antibodies to detect influenza viruses. More...


Influenza is a contagious disease, which causes over 150 million infections per year in the United States alone. A new study has demonstrated glycoconjugate-based viral capture and a potential path for the discriminatory detection of intact influenza viruses in the presence of the innate enzymatic activity of viral nucleic acids (NAs).

The capture of intact influenza viruses is of potential benefit for clinical diagnostics.
Conventional tests for influenza viruses, including avian flu, rely on antibodies to recognize viruses. However, antibody-based tests can be expensive and require refrigeration to remain stable. The test using sugar molecules requires no refrigeration and it can be used in remote areas of the world where new influenza viruses frequently emerge.

In a new study, Jurgen Schmidt, Ph.D., from the Los Alamos National Laboratory (NM, USA), Suri Iyer, Ph.D., assistant professor in the department of chemistry, University of Cincinnati, (OH, USA), and colleagues developed artificial forms of sialic acid, a sugar molecule found on the surface of cells that flu viruses attach to when they attack humans.

The scientists synthesized robust, biotinylated biantennary sialylglycoconjugates and demonstrated their ability to differentiate between two types of influenza A strains. In laboratory tests, they showed that the highly selective artificial sugars could be used to quickly capture and recognize two common strains of influenza viruses, H1N1, which infects birds, and H3N2, which infects pigs and humans. They used the molecules to differentiate between two strains (Sydney and Beijing) commonly found in human infections without isolating the viral RNA or surface glycoproteins. The sugars remain stable for several months, can be produced in large quantities, and exhibit extended shelf- life.

The new method appeared in the July 2, 2008 issue of the Journal of the American Chemical Society, a weekly publication.


Related Links:
Los Alamos National Laboratory
University of Cincinnati

Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gel Cards
DG Gel Cards
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: LiDia-SEQ aims to deliver near-patient NGS testing capabilities to hospitals, labs and clinics (Photo courtesy of DNAe)

World's First NGS-Based Diagnostic Platform Fully Automates Sample-To-Result Process Within Single Device

Rapid point-of-need diagnostics are of critical need, especially in the areas of infectious disease and cancer testing and monitoring. Now, a direct-from-specimen platform that performs genomic analysis... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more

Pathology

view channel
Image: The AI tool advances precision diagnostics by linking genetic mutations directly to disease types (Photo courtesy of Shutterstock)

AI Tool Simultaneously Identifies Genetic Mutations and Disease Type

Interpreting genetic test results remains a major challenge in modern medicine, particularly for rare and complex diseases. While existing tools can indicate whether a genetic mutation is harmful, they... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.